Skip to main content

Table 2 In vivo heart functional parameters by echocardiography at 3- and 14-d endpoints.

From: Early and Short-term Triiodothyronine Supplementation Prevents Adverse Postischemic Cardiac Remodeling: Role of Transforming Growth Factor-β1 and Antifibrotic miRNA Signaling

 

3 d

14 d

LV function

Sham

I/R-L

I/R-L+T3

Sham

I/R-L

I/R-L+T3

EDd (mm)

6.1 ± 0.3

6.2 ± 0.2

5.8 ± 0.2

6.3 ± 0.1

7.7 ± 0.1a,b

6.7 ± 0.1a

ESd (mm)

2.6 ± 0.2

3.2 ± 0.1a,b

2.5 ± 0.1

2.8 ± 0.6

4.4 ± 0.2a,b

3.1 ± 0.1

EDaw (mm)

1.6 ± 0.03

1.5 ± 0.05

1.6 ± 0.02

1.6 ± 0.04

1.2 ± 0.06

1.5 ± 0.06

EDpw (mm)

1.6 ± 0.02

1.6 ± 0.03

1.6 ± 0.02

1.6 ± 0.02

1.8 ± 0.03

1.7 ± 0.03

sAWT %

69 ± 4

51 ± 3a,b

68 ± 2

73 ± 3

55 ± 5a,b

72 ± 2

sPWT %

71 ± 4

65 ± 3

70 ± 3

72 ± 3

71 ± 3

71 ± 2

FS%

57 ± 2

46 ± 1a,b

57 ± 2

55 ± 1

43 ± 2a,b

54 ± 1

HR

458 ± 15b

448 ± 17b

490 ± 6

435 ± 12

401 ± 13

405 ± 14

  1. EDd, left ventricular end-diastole diameter; ESd, left ventricular end-systole diameter; EDaw, end diastolic anterior wall thickness; EDpw, end diastolic posterior wall thickness; sAWT%, percent systolic anterior wall thickening; sPWT%, percent systolic posterior wall thickening; sAWT%, percent of systolic anterior wall thickening; FS%, percent fractional shortening; HR, heart rate (bpm).
  2. Data are mean ± SEM; ap ≤ 0.01 sham; bp ≤ 0.01 versus I/R-L+T3.